SRPT - 3 Unstoppable Stocks That Could Double in 5 Years
Little Orphan Annie had it right: The sun will come out tomorrow. Although we're in a bear market now, stocks will rebound in time.
We asked three Motley Fool contributors which stocks they're especially optimistic about. Here's why they think that Ginkgo Bioworks Holdings (NYSE: DNA) , Novocure (NASDAQ: NVCR) , and Sarepta Therapeutics (NASDAQ: SRPT) are unstoppable stocks that could double in five years.
David Jagielski (Ginkgo Bioworks): If you're willing to wait five years, then one attractive growth stock to consider buying and holding right now is Ginkgo Bioworks. The stock has plunged nearly 70% year to date because of the current bear market and its lack of profitability. But Ginkgo certainly has the potential to double its current valuation .
For further details see:
3 Unstoppable Stocks That Could Double in 5 Years